Rabies and African bat lyssavirus encephalitis and its prevention

International Journal of Antimicrobial Agents

Volumn 36, Issue SUPPL. 1, 2010, Pages

  Warrell, Mary ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Africa; Bat; Lyssavirus; Rabies; Rabies recovery; Vaccine, intradermal

Indexed keywords

DIPLOID CELL VACCINE; RABIES VACCINE; UNCLASSIFIED DRUG; VAXIRAB;

ACTIVE IMMUNIZATION; AFRICA; AFRICAN BAT LYSSAVIRUS ENCEPHALITIS; AFRICAN VIRUS; ARTICLE; DRUG COST; DRUG EFFICACY; ENCEPHALITIS; GENOTYPE; HEALTH EDUCATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE; MORTALITY; NEUROLOGIC DISEASE; ONSET AGE; PASSIVE IMMUNIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABIES; RABIES VIRUS; RNA VIRUS; SKIN BIOPSY; SYMPTOMATOLOGY; TREATMENT DURATION; VACCINATION; VIRUS CULTURE; WOUND CARE;

AFRICA; ANIMALS; CHIROPTERA; DOGS; ENCEPHALITIS, VIRAL; HUMANS; LYSSAVIRUS; RABIES; RABIES VACCINES; VACCINATION; ZOONOSES;

EID: 77957943793     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.021     Document Type: Article

References (39)

1. Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005, 83:360-368.
2. W.H.O.expert consultation on rabies. WHO Technical Report Series 931 2005, World Health Organization, Geneva, http://www.wpro.who.int/NR/rdonlyres/B1ED8443-0993-408C-BF09-D1D06A6E1B45/0/FINALTEXTWHOTechnicalReportSeries090605.pdf [accessed 28 May 2010].
3. Nel L.H., Rupprecht C.E. Emergence of lyssaviruses in the Old World: the case of Africa. Curr Top Microbiol Immunol 2007, 315:161-193.
4. Matter H., Blancou J., Benelmouffok A., Hammami S., Fassi-Fehri N. Rabies in North Africa and Malta. Historical perspective of rabies in Europe and the Mediterranean basin 2004, 185-199. World Organization for Animal Health (OIE), Paris. A.A. King, A.R. Fooks, M. Aubert (Eds.).
5. Botros B.A., Moch R.W., Kerkor M., Helmy I. Rabies in the Arab Republic of Egypt: III Enzootic rabies in wildlife. J Trop Med Hyg 1977, 80:59-62.
6. Boulger L.R., Porterfield J.S. Isolation of a virus from Nigerian fruit bats. Trans R Soc Trop Med Hyg 1958, 52:421-424.
7. Nel L.H., Markotter W. Lyssaviruses. Crit Rev Microbiol 2007, 33:301-324.
8. El Sabban M.S., Fouad M.S., Hussein N., Sadek B. Bats and their relation to rabies in the United Arab Republic. Bull Off Int Epizoot 1967, 67:543-557.
9. Crick J. Rabies. Virus Diseases Of Food Animals 1981, vol II:469-516. Academic Press, London.
10. Van Thiel P.P., de Bie R.M., Eftimov F., Tepaske R., Zaaijer H.L., van Doornum G.J., et al. Fatal human rabies due to Duvenhage virus from a bat in Kenya: Failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis 2009, 3:e428.
11. Srinivasan A., Burton E.C., Kuehnert M.J., Rupprecht C., Sutker W.L., Ksiazek T.G., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005, 352:1103-1111.
12. Burton E.C., Burns D.K., Opatowsky M.J., El-Feky W.H., Fischbach B., Melton L., et al. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in four transplant recipients. Arch Neurol 2005, 62:873-882.
13. Rabies infections in organ donor transplant recipients in Germany (2005) Rabies Bull Euro 2005, 29(3):8-9. http://www.who-rabies-bulletin.org/Journal/Archive/Bulletin_2005_3.pdf [accessed 25 May 2010].
14. Mallewa M., Fooks A.R., Banda D., Chikungwa P., Mankhambo L., Molyneux E., et al. Rabies encephalitis in malaria-endemic area, Malawi, Africa. Emerg Infect Dis 2007, 13:136-139.
15. Dacheux L., Reynes J.M., Buchy P., Sivuth O., Diop B.M., Rousset D., et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 2008, 47:1410.
16. Warrell M.J., Warrell D.A. Rabies and other lyssavirus diseases. Lancet 2004, 363:959-969.
17. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005, 352:2508-2514.
18. Weli S.C., Scott C.A., Ward C.A., Jackson A.C. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity. J Virol 2006, 80:10270-10273.
19. Hattwick M.A., Weis T.T., Stechschulte C.J., Baer G.M., Gregg M.B. Recovery from rabies. Ann Intern Med 1972, 76:931-942. [A case report].
20. Preuss M.A., Faber M.L., Tan G.S., Bette M., Dietzschold B., Weihe E., et al. Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers. PLoS Pathog 2009, 5:e1000485.
21. Yan X., Prosniak M., Curtis M.T., Weiss M.L., Faber M., Dietzschold B., et al. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J Neurovirol 2001, 7:518-527.
22. Prosniak M., Zborek A., Scott G.S., Roy A., Phares T.W., Koprowski H., et al. Differential expression of growth factors at the cellular level in virus-infected brain. Proc Natl Acad Sci U S A 2003, 100:6765-6770.
23. Jackson A.C., Warrell M.J., Rupprecht C.E., Ertl H.C., Dietzschold B., O'Reilly M., et al. Management of rabies in humans. Clin Infect Dis 2003, 36:60-63.
24. Bourhy H., Goudal M., Mailles A., Sadkowska-Todys M., Dacheux L., Zeller H. Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?. Euro Surveill 2009, 14(13).
25. Dodet B. Report of the fifth AREB meeting Ho Chi Minh City, Vietnam, 17-20 November 2008. Vaccine 2009, 27:2403-2407.
26. Rabies prevention-United States, 1984 MMWR Morb Mortal Wkly Rep 1984, 33:393-402. 402-408.
27. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2007, 82:425-435.
28. Suwansrinon K., Jaijareonsup W., Wilde H., Benjavongkulchai M., Sriaroon C., Sitprija V. Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans R Soc Trop Med Hyg 2007, 101:206-208.
29. Warrell M.J., Nicholson K.G., Warrell D.A., Suntharasamai P., Chanthavanich P., Viravan C., et al. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985, 1(8437):1059-1062.
30. Chutivongse S., Wilde H., Supich C., Baer G.M., Fishbein D.B. Post-exposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990, 335. 896-8, 1.
31. WHO WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies 1997, World Health Organization, Geneva, WHO/EMC/ZOO. 96. 6 http://whqlibdoc.who.int/hq/1996/WHO_EMC_ZOO_96.6.pdf [accessed 27 April 2010].
32. Warrell M.J., Riddell A., Yu L.M., Phipps J., Diggle L., Bourhy H., et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis 2008, 2:e224.
33. Ambrozaitis A., Laiskonis A., Balciuniene L., Banzhoff A., Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine 2006, 24:4116-4121.
34. Suntharasamai P., Warrell M.J., Viravan C., Chanthavanich P., Looareesuwan S., Supapochana A., et al. Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis. Epidemiol Infect 1987, 99:755-765.
35. Tantawichien T., Benjavongkulchai M., Limsuwan K., Khawplod P., Kaewchompoo W., Chomchey P., et al. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Clin Infect Dis 1999, 28:1100-1103.
36. Khawplod P., Benjavongkulchai M., Limusanno S., Chareonwai S., Kaewchompoo W., Tantawichien T., et al. Four-site intradermal post-exposure boosters in previously rabies-vaccinated subjects. J Travel Med 2002, 9:153-155.
37. Reece J.F., Chawla S.K. Control of rabies in Jaipur, India, by the sterilisation and vaccination of neighbourhood dogs. Vet Rec 2006, 159:379-383.
38. Lembo T., Hampson K., Kaare M.T., Ernest E., Knobel D., Kazwala R.R., et al. The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis 2010, 4:e626.
39. Cenna J., Hunter M., Tan G.S., Papaneri A.B., Ribka E.P., Schnell M.J., et al. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J Infect Dis 2009, 200:1251-1260.